Single Photon Emission Computed Tomography (SPECT) is a nuclear medicine imaging technique that uses gamma-emitting radioactive tracers to visualize metabolic and molecular processes in the living brain. In neurodegenerative disease diagnosis, SPECT plays a crucial role particularly in evaluating dopaminergic function in [Parkinson's disease](/diseases/parkinsons-disease) and [atypical parkinsonian syndromes](/diseases/atypical-parkinsonism) including [multiple system atrophy](/diseases/multiple-system-atrophy), [progressive supranuclear palsy](/diseases/steele-richardson-olszewski-syndrome), and [corticobasal syndrome](/diseases/corticobasal-syndrome)[@brooks2004].
Principles of SPECT Imaging
How SPECT Works
Radiopharmaceutical administration: Patient receives an intravenous injection of a gamma-emitting radiotracer
Tracer uptake: The tracer accumulates in target tissues based on regional blood flow or specific receptor binding
Gamma emission: The radioactive decay releases gamma photons
Detection: Rotating gamma cameras detect photons from multiple angles
Reconstruction: Tomographic algorithms create cross-sectional images showing tracer distribution
Key SPECT Tracers in Neurodegeneration
...
Introduction
Mermaid diagram (expand to render)
Single Photon Emission Computed Tomography (SPECT) is a nuclear medicine imaging technique that uses gamma-emitting radioactive tracers to visualize metabolic and molecular processes in the living brain. In neurodegenerative disease diagnosis, SPECT plays a crucial role particularly in evaluating dopaminergic function in [Parkinson's disease](/diseases/parkinsons-disease) and [atypical parkinsonian syndromes](/diseases/atypical-parkinsonism) including [multiple system atrophy](/diseases/multiple-system-atrophy), [progressive supranuclear palsy](/diseases/steele-richardson-olszewski-syndrome), and [corticobasal syndrome](/diseases/corticobasal-syndrome)[@brooks2004].
Principles of SPECT Imaging
How SPECT Works
Radiopharmaceutical administration: Patient receives an intravenous injection of a gamma-emitting radiotracer
Tracer uptake: The tracer accumulates in target tissues based on regional blood flow or specific receptor binding
Gamma emission: The radioactive decay releases gamma photons
Detection: Rotating gamma cameras detect photons from multiple angles
Reconstruction: Tomographic algorithms create cross-sectional images showing tracer distribution
The most clinically significant application of SPECT in neurodegeneration is dopamine transporter (DAT) imaging using [123I]FP-CIT (commercially known as DaTscan). This technique:
Measures presynaptic dopaminergic integrity in the striatum
Differentiates parkinsonian disorders from non-degenerative conditions like essential tremor[@daparte1999]
Detects early Parkinson's disease even before clinical diagnosis[@catafau2006]
Supports differential diagnosis between PD, MSA, PSP, and CBS
DaTscan Findings in Neurodegenerative Diseases
| Disease | DaTscan Pattern | |---------|-----------------| | [Parkinson's disease](/diseases/parkinsons-disease) | Bilateral reduction in putaminal uptake | | [Multiple system atrophy](/diseases/multiple-system-atrophy) | Bilateral reduction, often symmetric | | [Progressive supranuclear palsy](/diseases/steele-richardson-olszewski-syndrome) | Bilateral reduction, more uniform | | [Corticobasal syndrome](/diseases/corticobasal-syndrome) | Often asymmetric reduction | | [Dementia with Lewy bodies](/diseases/dementia-lewy-bodies) | Reduced striatal binding | | [Vascular parkinsonism](/diseases/vascular-parkinsonism) | Variable pattern, often patchy |
Perfusion SPECT
Cerebral blood flow SPECT using 99mTc-HMPAO provides information about:
Regional hypoperfusion patterns in [dementias](/diseases/dementia-lewy-bodies)
Differentiation between [Alzheimer's disease](/diseases/alzheimers-disease) and [frontotemporal dementia](/diseases/behavioral-variant-ftd)
Assessment of disease progression in [corticobasal syndrome](/diseases/cerebral-metabolism-perfusion-cbs)
Perfusion Patterns by Disease
Corticobasal Syndrome
Perfusion SPECT in CBS shows characteristic asymmetric patterns:
Contralateral hypoperfusion to the more affected side
Frontal and parietal cortex involvement
Posterior cingulate preserved relative to other regions[@matsusue2020]
Progressive Supranuclear palsy
PSP demonstrates:
Midbrain hypoperfusion (relative to cerebellum)
Posterior frontal and precentral gyrus involvement
In [manganism](/diseases/manganism), DaTscan shows preserved dopamine transporter binding, distinguishing it from [Parkinson's disease](/diseases/parkinsons-disease)[@tsui2010][@kim2011]:
Normal FP-CIT uptake in striatum
Helps differentiate from classic Parkinsonian disorders
Emerging SPECT Applications
123I-PE2I Imaging
Novel DAT ligand with improved characteristics:
Higher affinity for dopamine transporter
Better signal-to-noise ratio
Potential for better quantification
123I-MIBG Cardiac Imaging
While technically a different modality, MIBG (metaiodobenzylguanidine) SPECT:
Evaluates cardiac sympathetic innervation
Supports DLB vs. AD differentiation
Reduced uptake in Lewy body disorders
Tau Imaging SPECT Tracers
While PET dominates tau imaging, SPECT tau tracers are in development:
Potential for broader accessibility
Lower cost compared to PET
Currently limited by resolution and sensitivity
Limitations and Challenges
Technical Limitations
Lower spatial resolution compared to PET
Radiation exposure (though lower than PET with some tracers)
Quantification challenges due to partial volume effects
Limited tomographic reconstruction compared to modern PET
Clinical Limitations
Cannot definitively diagnose specific disorders (only supports clinical impression)
Overlap in patterns between different disorders
Variable inter-operator and inter-site reliability
Limited sensitivity in early disease stages
Future Directions
Development of newer tracers with improved targeting
Hybrid SPECT/CT and SPECT/MRI systems
Quantitative SPECT with standardized uptake values
AI-assisted interpretation for improved accuracy
References
[Brooks et al., Dopamine transporter imaging with SPECT in parkinsonian syndromes (2004)](https://doi.org/10.1016/j.neurobiolaging.2004.02.014)
[Karantzoulis & Litvan, Resting motor cortex in corticobasal degeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/35725273/)
[Matsusue et al., Brain perfusion SPECT in corticobasal syndrome (2020)](https://pubmed.ncbi.nlm.nih.gov/32777729/)
[Pirker et al., Dopamine transporter SPECT in multiple system atrophy (2003)](https://doi.org/10.1002/mds.10395)
[Tsui et al., SPECT imaging in manganese-induced parkinsonism (2010)](https://doi.org/10.1016/j.jns.2010.08.024)
[Darcourt et al., The European DatSCAN protocol (1999)](https://pubmed.ncbi.nlm.nih.gov/10614784/)
[Catafau, SPECT neuroimaging in Parkinson's disease (2006)](https://pubmed.ncbi.nlm.nih.gov/16493173/)
[Booij et al., [123I]FP-CIT SPECT: a new method for dopamine transporter imaging (1999)](https://doi.org/10.1097/00004647-199909000-00010)